833 Results
Sort By:
Published on January 29, 2025
Yet another tool against COVID-19 has emerged in the form of a test that can determine how serious an individual’s after effects to the disease may be. A new study suggests it may be possible to predict who is most likely to experience follow-up disease symptoms based on their leukocyte…
Published on January 24, 2025
A new study has found the molecular signature of Long COVID in children’s plasma and used an AI tool test capable of making the diagnosis based on the results of the blood sample, with 93% accuracy. “The immunological data produced in this study provide the evidence needed to identify therapeutic…
Published on January 22, 2025
A large study led by the University of Texas Health Science Center at San Antonio shows that women infected with SARS-CoV-2 are more likely to go on to develop long COVID than men. Writing in JAMA Network Open, first author Dimpy Shah, MD, PhD, an assistant professor at UT Health…
Published on November 4, 2024
A new study conducted by researchers at the Albert Einstein College of Medicine indicates that the COVID-19 pandemic has led to a significant increase in the risk of dyslipidemia, a condition characterized by abnormal lipid levels in the blood. The research, which analyzed data from more than 200,000 adults, found…
Published on October 15, 2024
Ten to nineteen year olds had a 55% higher risk of a new type 2 diabetes (T2D) diagnosis one month after a COVID infection, compared with young people diagnosed with a non-COVID respiratory virus. The risk of TD2 diagnosis remained elevated at three months and six months, according to a…
Published on October 11, 2024
A persistent infection could explain why some people, but not others, develop long COVID symptoms, according to a new study led by researchers at the Brigham and Women’s Hospital. In a study of over 1,500 blood samples, the team found evidence of persistent infection in 43 percent of participants with…
Published on October 10, 2024
UK Biobank data has revealed that COVID-19 infection can increase the risk of heart attack, stroke, and death from any cause for at least up to three years. This trend was seen in people already diagnosed with and those without previously detected cardiovascular disease. Further, the risk of heart attack…
Published on September 30, 2024
A trial comparing the self-replicating mRNA-based COVID-19 vaccine, developed by U.S. biotech Arcturus Therapeutics in collaboration with CSL, with BioNTech/Pfizer’s Comirnaty vaccine shows it is able to elicit better immune responses 12 months after vaccination than the approved mRNA vaccine. The self-amplifying technology developed by Arcturus allows quick and long-lasting…
Published on September 25, 2024
Patients show substantial cognitive decline 12–18 months after hospitalization for COVID-19, a new year-long study of over 350 patients finds. The rate of decline, the researchers report, is comparable to 20 years of aging. Further, MRI scans and blood tests showed these patients had brain injury markers and reduced brain…
Published on September 4, 2024
People with obesity have a higher risk of contracting SARS-CoV-2, according to a new study led by researchers at Brigham and Women’s Hospital and Harvard Medical School. They used electronic medical record data on over 70,000 patients from their own hospital system. Obesity is known to predict worse outcomes and…
Published on August 29, 2024
A new study by researchers from the Gladstone Institutes and collaborators shows that the blood coagulation protein fibrin is the culprit that causes the unusual clotting and inflammation that are the primary symptoms of COVID-19. The discovery upends the prevailing view that blood clotting is a consequence of the inflammation…
Published on August 27, 2024
A new nasal COVID-19 vaccine is ready for clinical trials, said K. Anand Kumar, managing director of Indian Immunologicals and one of the co-authors of a new report on the vaccine. Called CDO-7N-1, it “induces robust mucosal and systemic neutralizing antibody and T-cell subset responses, in mice, hamsters, and macaques…
Published on August 23, 2024
A study funded by the National Institutes of Health (NIH) has found that while there are similar patterns of how long COVID affects virtually every organ system in both younger children and adolescents, younger children were more likely to experience headache, while those older were most likely to suffer from…
Published on August 22, 2024
A new study reveals higher incidence of mental illness for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to strongly mitigate mental illness. For example, the incidence of depression among the unvaccinated after hospitalization for COVID-19 was up to 16.3 times higher. This elevation in mental…
Published on August 13, 2024
In a cohort study of over 10,000 participants with and without prior SARS-CoV-2 infection, a handful of routine clinical laboratory tests were unable to provide a reliable biomarker of SARS-CoV-2 infection’s post-acute sequelae (PASC), also known as “long COVID.” The researchers also showed that all 25 tests failed to provide…